Personalized Rituximab Treatment Based on Artificial Intelligence in Membranous Nephropathy (iRITUX)
NCT06341205
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
120
Enrollment
OTHER
Sponsor class
Conditions
Membranous Nephropathy
Interventions
DRUG:
RiTUXimab Injection
Sponsor
Centre Hospitalier Universitaire de Nice